207 related articles for article (PubMed ID: 38374060)
1. Willingness to pay for an mRNA-based anti-cancer treatment: results from a contingent valuation study in Israel.
Ben-Aharon O; Sergienko R; Iskrov G; Greenberg D
Isr J Health Policy Res; 2024 Feb; 13(1):9. PubMed ID: 38374060
[TBL] [Abstract][Full Text] [Related]
2. Determining the Willingness to Pay for Innovative Oncology Medicines in Malaysia.
Dzulkipli MR; Shafie AA; Maon SN; Ramli A; Yahaya AHM; Ho SW; Muhsin NIA; Ahmat ANMF
Value Health Reg Issues; 2024 Mar; 40():19-26. PubMed ID: 37972430
[TBL] [Abstract][Full Text] [Related]
3. Willingness to pay for a National Health Insurance Scheme in The Gambia: a contingent valuation study.
Njie H; Wangen KR; Chola L; Gopinathan U; Mdala I; Sundby JS; Ilboudo PGC
Health Policy Plan; 2023 Jan; 38(1):61-73. PubMed ID: 36300926
[TBL] [Abstract][Full Text] [Related]
4. Estimating Willingness to Pay for an Improved Service Delivery to Patients Referring Namazi Hospital Chemical Therapy Ward in Iran Using Contingent Valuation.
Kavosi Z; Jafari A; Keshtkaran V; Pourahmadi E
Asian Pac J Cancer Prev; 2018 Jul; 19(7):1817-1823. PubMed ID: 30049193
[TBL] [Abstract][Full Text] [Related]
5. Valuing a hypothetical cure for rheumatoid arthritis using the contingent valuation methodology: the patient perspective.
Fautrel B; Clarke AE; Guillemin F; Adam V; St-Pierre Y; Panaritis T; Fortin PR; Menard HA; Donaldson C; Penrod JR
J Rheumatol; 2005 Mar; 32(3):443-53. PubMed ID: 15742435
[TBL] [Abstract][Full Text] [Related]
6. The acceptance and willingness to pay (WTP) for hypothetical dengue vaccine in Penang, Malaysia: a contingent valuation study.
Yeo HY; Shafie AA
Cost Eff Resour Alloc; 2018; 16():60. PubMed ID: 30479577
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of willingness to pay per quality-adjusted life year for a cure: A contingent valuation method using a scenario-based survey.
Song HJ; Lee EK
Medicine (Baltimore); 2018 Sep; 97(38):e12453. PubMed ID: 30235732
[TBL] [Abstract][Full Text] [Related]
8. Willingness-to-Accept and Willingness-to-Pay Ratios of Prevention of Mother-to-Child Transmission Services in a Nigerian Hospital: A Cross-Sectional Contingent Valuation Study.
Isah A; Adibe MO; Anosike C; Aluh DO; Onyekwelu PO; Okonta MJ; Ukwe CV
Value Health Reg Issues; 2019 Sep; 19():112-121. PubMed ID: 31404819
[TBL] [Abstract][Full Text] [Related]
9. Willingness to Pay for National Health Insurance: A Contingent Valuation Study Among Patients Visiting Public Hospitals in Melaka, Malaysia.
Tan RTH; Abdul Rasid SZ; Wan Ismail WK; Tobechan J; Tan ETY; Yusof AN; Low JH
Appl Health Econ Health Policy; 2022 Mar; 20(2):255-267. PubMed ID: 34927225
[TBL] [Abstract][Full Text] [Related]
10. Willingness to pay for social health insurance among informal sector workers in Wuhan, China: a contingent valuation study.
Bärnighausen T; Liu Y; Zhang X; Sauerborn R
BMC Health Serv Res; 2007 Jul; 7():114. PubMed ID: 17659084
[TBL] [Abstract][Full Text] [Related]
11. Willingness to pay for HPV vaccine among female health care workers in a Chinese nationwide survey.
Lu X; Ji M; Wagner AL; Huang W; Shao X; Zhou W; Lu Y
BMC Health Serv Res; 2022 Nov; 22(1):1324. PubMed ID: 36335333
[TBL] [Abstract][Full Text] [Related]
12. Eliciting willingness-to-pay to prevent hospital medication administration errors in the UK: a contingent valuation survey.
Hill SR; Bhattarai N; Tolley CL; Slight SP; Vale L
BMJ Open; 2022 Feb; 12(2):e053115. PubMed ID: 35105580
[TBL] [Abstract][Full Text] [Related]
13. The willingness to pay for in vitro fertilization: a pilot study using contingent valuation.
Neumann PJ; Johannesson M
Med Care; 1994 Jul; 32(7):686-99. PubMed ID: 8028404
[TBL] [Abstract][Full Text] [Related]
14. Examining Willingness-to-Pay and Zero Valuations for a Health Improvement with Logistic Regression.
Mavrodi AG; Chatzopoulos SA; Aletras VH
Inquiry; 2021; 58():469580211028102. PubMed ID: 34271848
[TBL] [Abstract][Full Text] [Related]
15. Willingness to pay for social health insurance and its determinants among public servants in Mekelle City, Northern Ethiopia: a mixed methods study.
Gidey MT; Gebretekle GB; Hogan ME; Fenta TG
Cost Eff Resour Alloc; 2019; 17():2. PubMed ID: 30675133
[TBL] [Abstract][Full Text] [Related]
16. Willingness to pay for cancer prevention, screening, diagnosis, and treatment: a systematic review.
Ben-Aharon O; Iskrov G; Sagy I; Greenberg D
Expert Rev Pharmacoecon Outcomes Res; 2023 Mar; 23(3):281-295. PubMed ID: 36635646
[TBL] [Abstract][Full Text] [Related]
17. Willingness to pay for private health insurance among workers with mandatory social health insurance in Mongolia.
Batbold O; Pu C
Int J Equity Health; 2021 Jan; 20(1):7. PubMed ID: 33407534
[TBL] [Abstract][Full Text] [Related]
18. Consumers' willingness to pay for pharmacy services that reduce risk of medication-related problems.
Suh DC
J Am Pharm Assoc (Wash); 2000; 40(6):818-27. PubMed ID: 11111362
[TBL] [Abstract][Full Text] [Related]
19. Contingent Valuation: A Pilot Study for Eliciting Willingness to Pay for a Reduction in Mortality From Vaccine-Preventable Illnesses for Children and Adults in Bangladesh.
Odihi D; De Broucker G; Hasan Z; Ahmed S; Constenla D; Uddin J; Patenaude B
Value Health Reg Issues; 2021 May; 24():67-76. PubMed ID: 33508753
[TBL] [Abstract][Full Text] [Related]
20. Willingness to pay for packaging cancer screening of Chinese rural residents.
Zhang Q; Ren D; Chang X; Sun C; Liu R; Wang J; Zhang N
Cancer Med; 2023 Feb; 12(3):3532-3542. PubMed ID: 36000818
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
